Phd Candidate
CurrentThe Jenkins Laboratory has expertise in the preclinical development and validation of novel immunotherapies to treat severe brain cancers. My PhD project explores how the latest cutting-edge innovations for synthetic receptor design can be harnessed to create smarter and safer Chimeric Antigen Receptor T cell therapies to treat High Grade Gliomas.